Back to search

Article

<i>TET2</i> lesions enhance the aggressiveness of <i>CEBPA-</i> mutant AML by rebalancing <i>GATA2</i> expression

2023-03-29

Abstract excerpt

<h4>ABSTRACT</h4> The myeloid transcription factor CEBPA is recurrently biallelically mutated (i.e., double mutated; CEBPA DM ) in acute myeloid leukemia (AML) with a combination of hypermorphic N-terminal mutations ( CEBPA NT ), promoting expression of the leukemia-associated p30 isoform, and amorphic C-terminal mutations. The most frequently co-mutated genes in CEBPA DM AML are GATA2 and TET2 , however the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a2c04c15-d486-512f-a396-95013ceff88b
DOI
10.1101/2023.03.28.534511
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>TET2</i> lesions enhance the aggressiveness of <i>CEBPA-</i> mutant AML by rebalancing <i>GATA2</i> expressionDOI 10.1101/2023.03.28.534511
Select a neighboring publication to make it the new centre.